Filing Details
- Accession Number:
- 0001209191-19-021092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-22 19:42:20
- Reporting Period:
- 2019-03-21
- Accepted Time:
- 2019-03-22 19:42:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1668243 | Urogen Pharma Ltd. | URGN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1763581 | Mark Schoenberg | C/O Urogen Pharma Ltd. 9 Ha?Ta?Asiya Street Ra?Anana L3 4365007 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-03-21 | 272 | $37.01 | 4,610 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person's purchase of Ordinary Shares of the Issuer reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's sale of 272 Ordinary Shares of the Issuer at a price of $37.30 per share on March 6, 2019. The reporting person has agreed to pay to the Issuer $79.15, representing the full amount of the profit realized in connection with the short-swing transaction.
Billionaire Hedge Funds
